After signing up, you'll start to receive regular news updates from us.
Chiral Quest Subsidiary Signs License Agreement with

Complete the form below to unlock access to ALL audio articles.
VioQuest's subsidiary Chiral Quest, Inc., (VQPH) signed a licensing agreement granting Merck & Co., Inc. use of its catalysts for the process development and manufacture of single-enantiomer intermediates and active pharmaceutical ingredients.
This agreement provides Merck with access to a broad range of proprietary ligands and catalysts.